Liveon Biolabs Private Limited - Due diligence report

A 360° intelligence report on Liveon Biolabs: trust score, financial health, credit view, compliance, directors, growth and distress signals…

2011-04-06 Tumkur, Karnataka Active Unlisted Active Compliant
Share
Connect MCP
LB Liveon Biolabs Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Liveon Biolabs — 360° Intelligence Report

Generated from MCA filings & public records
70/100
Trust Score
Moderate

Liveon Biolabs is assessed as Moderate with a Trust Score of 70/100. Liveon Biolabs is an active private limited indian non-government company incorporated in 2011, operating in the Life Sciences sector. The company has shown revenue growth across its recent filed years. It reported a loss in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and high financial risk profile.

Report generated on 04 Aug 2026 from the latest processed filings. Liveon Biolabs Private Limited snapshot & full profile →

Financial Health › Weak
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
70/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
70/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreCaution Indicated
35/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
20/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
90/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
65/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
75/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 20/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Elevated gearing (D/E 1.42).

Charges position: 3 open (17.13 cr) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
State Bank Of India1 48.0 cr
Others2 48.0 cr
Compliance Score: 70/100 Moderate
  • Company status is Active as per MCA.
  • Annual filings current (balance sheet Mar 2025).
  • Flagged by authority: EPFO.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 90/100
NameDIN / PANDesignationAppointedTenureDIN status
HANAKERE PUTTAMADU SWETHA 01234567 Director 01/04/2018 6 yrs Approved
GOLLAHALLI BASAVARAJU 01234567 Director 01/04/2018 6 yrs Approved
CHANNARAYAPPA RAAJU 01234567 Director 01/04/2018 6 yrs Approved
  • 3 directors on the board.
  • No disqualified or deactivated DINs.
  • 1 director exit(s) in the last 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2017)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
6 allotment(s) · 9 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 65 · Distress 75
Growth signals & trust indicators
Steady revenue growth: +2.1x over 4 year(s).
Asset base grew 24% - capacity expansion.
Operating for 15+ years.
Active EPFO - real payroll on record.
Active GST registration(s).
Distress signals & risk flags
Losses deepening year-on-year.
3 open charge(s) registered - assets are encumbered.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence72/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment37/100
Enhanced diligence advised
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 3 open charge(s) of 17.13 cr already registered.
  • Compliance record supports lending.
Investor view56/100
Mixed indicators
Growth quality and scalability through an investor lens.
  • 2 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
30 Sep 2025
Last AGM held
Annual general meeting
31 Mar 2025
Latest balance sheet
Filed with ROC
05 Sep 2024
Director ceased
NAGARAJU CHETAN
21 Oct 2022
Director appointed
HANAKERE PUTTAMADU SWETHA (Additional Director)
10 Jan 2022
Securities allotted
342703 Equity Shares - 63.40 Lakh raised
19 Aug 2021
Director ceased
SHREYAS RANGAPPA
31 Mar 2021
Share transfer (FY 2021)
23809.00000000 shares to Shivashankar N G
Share transfer (FY 2021)
7500.00000000 shares to Jyothi G
Share transfer (FY 2021)
192852.00000000 shares to Shivashankar N G
Share transfer (FY 2021)
109523.00000000 shares to Shivashankar N G
Share transfer (FY 2021)
85010.00000000 shares to Shivashankar N G
30 Nov 2020
Securities allotted
62500 Equity Shares - 10.00 Lakh raised
08 Jun 2020
Director ceased
GANGAPPA KEMPAIAH
Director ceased
KRISHNAMURTHY NARASIMHASHASTHRI LAKKUR
31 Mar 2018
Share transfer (FY 2018)
28570.00000000 shares to Swetha H P
10

Key Observations

Auto-generated from the data above
Revenue grew 0.86 over the last 4 financial year(s).
Net profit margin moved from 61% to 38%.
Debt-to-equity stands at 1.42 - leverage worth monitoring.
Net worth is positive.
3 active director(s) / partner(s); board looks stable and experienced.
1 active GST registration(s) indicate ongoing business operations.
EPFO-registered employer - verifiable payroll history exists.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 6 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Numentica Technologies Private Limited U72900TZ2018PTC030345 Coimbatore North, Tamil Nadu, India
Sterdill Equipments Private Limited U33119MH1989PTC054802 Navi Mumbai, Maharashtra, India
Social Cloud Ventures U72200DL2011PTC228994 New Delhi, Delhi, India
Xemplar Infosoft Insights Private Limited U72900TG2018PTC124487 Survey No. 88, Madhapur, Telangana, India
Be-Bonnie Bodycare Private Limited U93000WB2014PTC201877 Kolkata, West Bengal, India
Tinkerly U74999RJ2015PTC067250 Jaipur, Rajasthan, India
Cubictree Technology Solutions U72900MH2009PTC196963 Mumbai, Maharashtra, India
Shiv Shakti Embroideries Private Limited U18101DL1997PTC089114 Delhi, Delhi, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Liveon Biolabs before audits and certifications: compliance score 70/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Liveon Biolabs: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Enhanced diligence advised. Credit risk score 20/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Mixed indicators. Growth score 65/100, margin trends, ownership structure and peer set for Liveon Biolabs - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 70/100, distress signals and MSME payment-delay disclosures - know whether Liveon Biolabs pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Liveon Biolabs - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Liveon Biolabs an active company?

Liveon Biolabs has MCA status “Active” with a compliance score of 70/100 (Moderate).

Is Liveon Biolabs financially healthy?

Liveon Biolabs has a Financial Health Score of 35/100 (Caution Indicated) based on its filed financial statements.

Should I do business with Liveon Biolabs?

Its overall Trust Score is 70/100 (Moderate). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Liveon Biolabs?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 3 active director(s) are on record.

Does Liveon Biolabs have loans or charges against its assets?

3 open charge(s) are registered against its assets.

Is Liveon Biolabs up to date with its ROC filings?

Annual filings current (balance sheet Mar 2025). Overall compliance score: 70/100 (Moderate).

Is it risky to lend to Liveon Biolabs?

Its Credit Risk Score is 20/100 (Caution Indicated). Banker verdict: Enhanced diligence advised.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.